375 related articles for article (PubMed ID: 21233290)
1. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis.
Cao Y; Ma J
Cancer Prev Res (Phila); 2011 Apr; 4(4):486-501. PubMed ID: 21233290
[TBL] [Abstract][Full Text] [Related]
2. Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients.
Hu MB; Xu H; Bai PD; Jiang HW; Ding Q
Med Oncol; 2014 Feb; 31(2):829. PubMed ID: 24390417
[TBL] [Abstract][Full Text] [Related]
3. Obesity and long-term survival after radical prostatectomy.
Chalfin HJ; Lee SB; Jeong BC; Freedland SJ; Alai H; Feng Z; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
J Urol; 2014 Oct; 192(4):1100-4. PubMed ID: 24769031
[TBL] [Abstract][Full Text] [Related]
4. Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy.
van Roermund JG; Hinnen KA; Battermann JJ; Witjes JA; Bosch JL; Kiemeney LA; van Vulpen M
BJU Int; 2010 Jan; 105(1):42-8. PubMed ID: 19519759
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality.
Wright ME; Chang SC; Schatzkin A; Albanes D; Kipnis V; Mouw T; Hurwitz P; Hollenbeck A; Leitzmann MF
Cancer; 2007 Feb; 109(4):675-84. PubMed ID: 17211863
[TBL] [Abstract][Full Text] [Related]
6. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer.
Palma D; Pickles T; Tyldesley S;
BJU Int; 2007 Aug; 100(2):315-9. PubMed ID: 17617138
[TBL] [Abstract][Full Text] [Related]
7. Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis.
Doleman B; Mills KT; Lim S; Zelhart MD; Gagliardi G
Tech Coloproctol; 2016 Aug; 20(8):517-35. PubMed ID: 27343117
[TBL] [Abstract][Full Text] [Related]
8. The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence.
Xiang YZ; Xiong H; Cui ZL; Jiang SB; Xia QH; Zhao Y; Li GB; Jin XB
J Exp Clin Cancer Res; 2013 Feb; 32(1):9. PubMed ID: 23406686
[TBL] [Abstract][Full Text] [Related]
9. The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance.
Ploussard G; de la Taille A; Bayoud Y; Durand X; Terry S; Xylinas E; Allory Y; Vacherot F; Abbou CC; Salomon L
Eur Urol; 2012 Feb; 61(2):356-62. PubMed ID: 21803484
[TBL] [Abstract][Full Text] [Related]
10. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.
Rodriguez C; Patel AV; Calle EE; Jacobs EJ; Chao A; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):345-53. PubMed ID: 11319175
[TBL] [Abstract][Full Text] [Related]
11. Tobacco smoking and survival after a prostate cancer diagnosis: A systematic review and meta-analysis.
Darcey E; Boyle T
Cancer Treat Rev; 2018 Nov; 70():30-40. PubMed ID: 30055462
[TBL] [Abstract][Full Text] [Related]
12. Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer.
Troeschel AN; Hartman TJ; Jacobs EJ; Stevens VL; Gansler T; Flanders WD; McCullough LE; Wang Y
J Clin Oncol; 2020 Jun; 38(18):2018-2027. PubMed ID: 32250715
[TBL] [Abstract][Full Text] [Related]
13. Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients.
Rivera-Izquierdo M; Pérez de Rojas J; Martínez-Ruiz V; Arrabal-Polo MÁ; Pérez-Gómez B; Jiménez-Moleón JJ
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):411-421. PubMed ID: 34987170
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality.
Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
J Urol; 2017 Apr; 197(4):1060-1067. PubMed ID: 27847296
[TBL] [Abstract][Full Text] [Related]
15. Sedentary Behavior and Prostate Cancer: A Systematic Review and Meta-Analysis of Prospective Cohort Studies.
Berger FF; Leitzmann MF; Hillreiner A; Sedlmeier AM; Prokopidi-Danisch ME; Burger M; Jochem C
Cancer Prev Res (Phila); 2019 Oct; 12(10):675-688. PubMed ID: 31362941
[TBL] [Abstract][Full Text] [Related]
16. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men.
Gong Z; Agalliu I; Lin DW; Stanford JL; Kristal AR
Cancer; 2007 Mar; 109(6):1192-202. PubMed ID: 17311344
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis.
Zhong S; Yan X; Wu Y; Zhang X; Chen L; Tang J; Zhao J
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):122-31. PubMed ID: 26754262
[TBL] [Abstract][Full Text] [Related]
18. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™).
Tat D; Kenfield SA; Cowan JE; Broering JM; Carroll PR; Van Blarigan EL; Chan JM
Prostate; 2018 Jan; 78(1):32-39. PubMed ID: 29105845
[TBL] [Abstract][Full Text] [Related]
19. Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies.
Discacciati A; Orsini N; Wolk A
Ann Oncol; 2012 Jul; 23(7):1665-71. PubMed ID: 22228452
[TBL] [Abstract][Full Text] [Related]
20. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
Bassett WW; Cooperberg MR; Sadetsky N; Silva S; DuChane J; Pasta DJ; Chan JM; Anast JW; Carroll PR; Kane CJ
Urology; 2005 Nov; 66(5):1060-5. PubMed ID: 16286124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
